PriceTracker GLP-1
Loading the index…

Try

Loading the index…

Try

GLP-1 TV · Patient story · views checked Oct 2026

Wegovy 5 month review | 40 + LBS Lost!!! | End of the first chapter?

Patient storyDown2Fit14,844 views7:01Apr 2022

Our summary

In this five-month update on Wegovy, the creator says he has lost 40.2 pounds and now weighs 268 pounds, his first time below 270. He took his first 2.4 dose the previous week. He says the night of the injection brought strong nausea and he could not face food, but he took Zofran, felt better the next day and has had no stomach aches since. He says reaching 2.4 took five months rather than the roughly five weeks he believes it should, a slow pace he chose on purpose.

One person's experience, in their words. Not medical advice.

What else the video covers

Much of the video covers insurance. He says his prior authorization was expiring, and his doctor first asked to keep him on 1.7 because he was nervous about side effects. According to him, the insurer replied that the tiering required a 2.4 prescription. After that was submitted, he says coverage was denied on the grounds that he had not lost five percent of his baseline weight. He calculates his loss as 7.68 percent of 309 pounds, does not understand the denial, and says an appeal has been filed. He has three doses left.

He says he expects coverage may not last, since he describes the drug as costing 1600 a month, and that his doctor warned him of this. If he loses access, he plans to continue the eating and lifestyle changes he has made and accepts that weight may come off more slowly. He credits his loss partly to more cardio and attention to food, mentions missing an injection for about 10 days, and says appetite is mostly manageable. He also promotes his TikTok cardio challenge.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 He says his first 2.4 dose caused strong nausea that night, eased with Zofran the next day, and he has had no stomach aches since.
  2. 1:01 He explains it took him five months to reach 2.4, which he believes should take about five weeks, and that the slow pace was deliberate.
  3. 1:31 He says his doctor asked to stay on 1.7, but the insurer insisted the prior authorization could only be approved for 2.4.
  4. 2:02 He reports the 2.4 prescription was denied for not losing five percent of baseline weight, though he calculates a 7.68 percent loss, and an appeal was filed.
  5. 3:00 He says that with a 1600 a month medication, long-term coverage is unlikely, so he plans to keep his lifestyle changes with or without it.
  6. 4:37 He reports weighing 268 pounds, down more than 40 pounds, and credits increased cardio and careful eating.

Key moments

Where the talk turns, found in the captions. Tap one to play from there.

  1. 0:28 Side effects
  2. 2:27 Cost and insurance
  3. 4:45 Weigh-in and results
  4. 5:44 Food noise and cravings

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Wegovy
Point in the journey
Month 5
Side effects mentioned
nausea
Who is speaking
Patient

Questions this video answers

What side effects did he have on his first Wegovy 2.4 dose?

He says he was very nauseous the night he took it and could not stomach the thought of food. He took Zofran, felt better the next day, ate something small that afternoon and reports no stomach aches since.

How much weight did he lose on Wegovy in 5 months?

He says he is down 40.2 pounds, from a starting weight of 309 pounds to 268 pounds. He calculates this as 7.68 percent of his body weight.

Why did insurance deny his Wegovy 2.4 dose?

He says the denial cited a requirement to lose five percent of baseline weight. He believes he has already passed that mark, so his doctor submitted an appeal.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Wegovy 7.2 mg (Wegovy HD): what the higher dose adds, and what it costs

    Wegovy HD is semaglutide at 7.2 mg, three times the standard 2.4 mg dose, in its own pen. In the STEP UP trial it took 18.7% off body weight at 72 weeks against 15.6% for 2.4 mg and 3.9% for placebo, in 1,407 adults with obesity. That puts it within 1.5 points of tirzepatide's head-to-head result and makes it the strongest semaglutide there is. Novo sells it direct for $399 a month, $50 above the standard pen, and it sits above the normal ladder rather than replacing it.

  • Wegovy side effects, and why the top of the ladder is different

    Wegovy's side effects are semaglutide's side effects: nausea, vomiting, diarrhoea and constipation, worst in the first weeks and after each dose increase. What makes Wegovy different from Ozempic is not the molecule but the destination. Wegovy is dosed for weight management, climbing to 2.4 mg with a 7.2 mg high-dose strength above it, and dose is the main driver of how pronounced the gastrointestinal effects get. It also carries a boxed warning for thyroid C-cell tumour risk. One useful fact while you decide whether to push through: Novo's self-pay price is flat across every pen dose, so a slower climb costs a brand patient nothing.

  • The best GLP-1 for weight loss, ranked by the evidence and then by the bill

    By weight lost, the order is settled: tirzepatide (Zepbound) first at 20.2% in the only head-to-head, then semaglutide 7.2 mg (Wegovy HD) at 18.7%, then semaglutide 2.4 mg (Wegovy) at 13.7% to 15.6%, then the pills. By what you pay, the order nearly inverts: compounded semaglutide from $69 a month, the Wegovy tablet from $149, Wegovy pen $349, Zepbound $299 to $699 by dose. The best one is where those two lists meet for your budget and your plan.

Find more like it

Side effectsDose changeWeigh-in and resultsCost and insuranceNausea

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV